Close Window

Digital Look Email A Friend

Boost for Oxford Biomedica as Novartis files for further blood cancer indication

Published by Oliver Haill on 31st October 2017

(ShareCast News) - Oxford Biomedica received a boost as Novartis announced that it has filed for approval of its Kymriah drug for a second blood cancer indication.

URL: http://www.digitallook.com/dl/news/story/26636663/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.